Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is an aggressive malignancy of the brain and spinal cord with a poor life expectancy. The low survivability of GBM patients can be attributed, in part, to its heterogeneity and the presence of multiple genetic alterations causing rapid tumor growth and resistance to con...
Main Authors: | Nadia Al-Sammarraie, Swapan K. Ray |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2342 |
Similar Items
-
Advanced Bioinformatics Analysis and Genetic Technologies for Targeting Autophagy in Glioblastoma Multiforme
by: Amanda J. Manea, et al.
Published: (2023-03-01) -
Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities
by: Rhett Visintin, et al.
Published: (2022-12-01) -
Role of extent of resection on the survival of glioblastoma multiforme
by: Dipak Chaulagain, et al.
Published: (2023-06-01) -
The CRISPR/Cas system: Gene Editing by bacterial defense
by: Amira H. El-Ashry
Published: (2023-09-01) -
Editorial: Improving responses to immunotherapy in glioblastoma multiforme
by: Stephanie E. B. McArdle, et al.
Published: (2024-04-01)